See more : Gruma, S.A.B. de C.V. (GPAGF) Income Statement Analysis – Financial Results
Complete financial analysis of Optimax Holdings Berhad (0222.KL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Optimax Holdings Berhad, a leading company in the industry within the sector.
- Cenkos Securities plc (CNKS.L) Income Statement Analysis – Financial Results
- MediaValet Inc. (MVP.TO) Income Statement Analysis – Financial Results
- Aopen Inc. (3046.TW) Income Statement Analysis – Financial Results
- Shanghai Haohai Biological Technology Co., Ltd. (688366.SS) Income Statement Analysis – Financial Results
- Gogo Inc. (0IYQ.L) Income Statement Analysis – Financial Results
Optimax Holdings Berhad (0222.KL)
Website: https://www.optimax2u.com
About Optimax Holdings Berhad
Optimax Holdings Berhad, an investment holding company, provides eye specialist services and related products in Malaysia. The company's specialist centers offer a range of treatments relating to eye diseases, such as cataracts, glaucoma, dry eye, conjunctivitis, age-related macular degeneration, diabetic retinopathy, retinal detachment, pterygium, keratoconus, ptosis, and other eye diseases and disorders. It also provides refractive surgery, consultation and dispensary, oculoplastic surgery, and eye examination services. In addition, the company markets food products. It serves international patients from Indonesia, the Philippines, Singapore, Thailand, Australia, China, Hong Kong, and Japan. The company was founded in 1995 and is headquartered in Kuala Lumpur, Malaysia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 114.12M | 108.00M | 88.90M | 58.02M | 62.71M |
| Cost of Revenue | 70.33M | 23.63M | 19.47M | 12.09M | 36.49M |
| Gross Profit | 43.78M | 84.37M | 69.43M | 45.93M | 26.21M |
| Gross Profit Ratio | 38.37% | 78.12% | 78.10% | 79.16% | 41.80% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 2.80M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 1.05M |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 3.85M |
| Other Expenses | 22.54M | 0.00 | 169.00K | 230.00K | 25.00K |
| Operating Expenses | 22.54M | 59.74M | 49.77M | 35.07M | 3.88M |
| Cost & Expenses | 92.87M | 83.38M | 69.24M | 47.16M | 3.88M |
| Interest Income | 205.00K | 108.00K | 191.00K | 31.00K | 48.00K |
| Interest Expense | 1.44M | 1.23M | 1.26M | 1.54M | 1.46M |
| Depreciation & Amortization | 7.34M | 7.82M | 6.58M | 5.96M | 3.90M |
| EBITDA | 28.59M | 32.56M | 26.43M | 17.17M | 17.89M |
| EBITDA Ratio | 25.05% | 30.14% | 29.73% | 29.58% | -6.18% |
| Operating Income | 21.24M | 24.63M | 19.66M | 11.09M | -3.88M |
| Operating Income Ratio | 18.62% | 22.80% | 22.11% | 19.11% | -6.18% |
| Total Other Income/Expenses | -1.23M | -1.12M | -1.07M | -1.42M | -1.41M |
| Income Before Tax | 20.01M | 23.51M | 18.59M | 9.67M | 12.57M |
| Income Before Tax Ratio | 17.53% | 21.76% | 20.91% | 16.67% | 20.05% |
| Income Tax Expense | 5.73M | 7.09M | 5.49M | 3.26M | 3.83M |
| Net Income | 12.89M | 14.69M | 12.30M | 5.64M | 7.83M |
| Net Income Ratio | 11.30% | 13.60% | 13.83% | 9.72% | 12.49% |
| EPS | 0.02 | 0.03 | 0.02 | 0.01 | 0.02 |
| EPS Diluted | 0.02 | 0.03 | 0.02 | 0.01 | 0.02 |
| Weighted Avg Shares Out | 540.17M | 540.00M | 540.00M | 458.34M | 400.01M |
| Weighted Avg Shares Out (Dil) | 561.06M | 550.34M | 675.00M | 593.33M | 400.00M |
Source: https://incomestatements.info
Category: Stock Reports